Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Potassium canrenoate
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Other names | SC-14266 |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Intravenous |
ATC code | |
Pharmacokinetic data | |
Metabolism | Hepatic |
Excretion | Renal and fecal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.016.868 |
Chemical and physical data | |
Formula | C22H29KO4 |
Molar mass | 396.568 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Potassium canrenoate (INN, JAN) or canrenoate potassium (USAN) (brand names Venactone, Soldactone), also known as aldadiene kalium, the potassium salt of canrenoic acid, is an aldosterone antagonist of the spirolactone group. Like spironolactone, it is a prodrug, and is metabolized to active canrenone in the body.
Potassium canrenoate is notable in that it is the only clinically used antimineralocorticoid which is available for parenteral administration (specifically intravenous) as opposed to oral administration.
In the UK it is unlicensed and only used for short term diuresis in oedema or heart failure in neonates or children under specialist initiation and monitoring.
See also
Sulfonamides (and etacrynic acid) |
|
||||||||
---|---|---|---|---|---|---|---|---|---|
Potassium-sparing (at CD) |
|
||||||||
Osmotic diuretics (PT, DL) | |||||||||
Vasopressin receptor inhibitors (DCT and CD) |
|||||||||
Other | |||||||||
Combination products | |||||||||
|
Mineralocorticoids | |
---|---|
Antimineralocorticoids | |
Synthesis modifiers | |
|
MR |
|
||||
---|---|---|---|---|---|
PR |
|
||||||
---|---|---|---|---|---|---|---|
mPR (PAQR) |
|
||||||
AR |
|
||||||
---|---|---|---|---|---|---|---|
GPRC6A |
|
||||||